Moore Capital Management, LP Seagen Inc. Transaction History

Moore Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $11.1 Million - $12.5 Million	58,000 Added 483.33%	70,000 $14.9 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $1.5 Million - $1.65 Million	-8,000 Reduced 40.0%	12,000 $2.31 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $2.55 Million - $4.06 Million	20,000 New	20,000 $4.05 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $13.2 Million - $21.7 Million	-121,177 Reduced 88.45%	15,825 $2.8 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $4.06 Million - $5.36 Million	-33,964 Reduced 19.87%	137,002 $19.7 Million

Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $3.27 Million - $4.37 Million	22,918 Added 15.48%	170,966 $26.4 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $2.96 Million - $3.53 Million	-20,767 Reduced 12.3%	148,048 $25.1 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $9.44 Million - $11.3 Million	69,899 Added 70.67%	168,815 $26.7 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $13.6 Million - $18.9 Million	98,916 New	98,916 $13.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.